These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 8937445)
1. Effects of chronic oral treatment with GABA-transaminase inhibitors on the GABA system in brain, liver, kidney, and plasma of the rat. Qume M; Fowler LJ Biochem Pharmacol; 1996 Nov; 52(9):1355-63. PubMed ID: 8937445 [TBL] [Abstract][Full Text] [Related]
2. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus. Qume M; Fowler LJ Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512 [TBL] [Abstract][Full Text] [Related]
3. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus. Qume M; Whitton PS; Fowler LJ J Neurochem; 1995 May; 64(5):2256-61. PubMed ID: 7722510 [TBL] [Abstract][Full Text] [Related]
4. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration. Valdizán EM; Armijo JA Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502 [TBL] [Abstract][Full Text] [Related]
5. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain. Cubells JF; Blanchard JS; Smith DM; Makman MH J Pharmacol Exp Ther; 1986 Aug; 238(2):508-14. PubMed ID: 3735130 [TBL] [Abstract][Full Text] [Related]
6. A regional study of 4-aminobutyrate metabolism and amino acid levels in rat brain following chronic oral administration of ethanolamine O-sulphate. Fletcher A; Fowler LJ J Neurochem; 1982 Apr; 38(4):1022-8. PubMed ID: 7062027 [TBL] [Abstract][Full Text] [Related]
7. Effects of ethanolamine-O-sulphate and gamma-acetylenic-GABA on GABA content, GAD and GABA-T in various areas of chick brain after intraventricular microinjection. Nisticó G; Di Giorgio RM; De Luca G; Macaione S J Neurochem; 1979 Jul; 33(1):343-6. PubMed ID: 458459 [No Abstract] [Full Text] [Related]
8. The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA). Manor D; Rothman DL; Mason GF; Hyder F; Petroff OA; Behar KL Neurochem Res; 1996 Sep; 21(9):1031-41. PubMed ID: 8897466 [TBL] [Abstract][Full Text] [Related]
9. Effect of 2-aminoethanol on the synthesis, binding, uptake and metabolism of GABA. Löscher W Neurosci Lett; 1983 Dec; 42(3):293-7. PubMed ID: 6320073 [TBL] [Abstract][Full Text] [Related]
10. Elevation of brain GABA levels with vigabatrin (gamma-vinylGABA) differentially affects GAD65 and GAD67 expression in various regions of rat brain. Sheikh SN; Martin DL J Neurosci Res; 1998 Jun; 52(6):736-41. PubMed ID: 9669322 [TBL] [Abstract][Full Text] [Related]
12. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina. Neal MJ; Shah MA Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037 [TBL] [Abstract][Full Text] [Related]
13. Effects of increasing doses of vigabatrin on platelet gamma-aminobutyric acid-transaminase and brain gamma-aminobutyric acid in rats. Valdizán EM; García AP; Armijo JA Eur J Pharmacol; 1999 Mar; 369(2):169-73. PubMed ID: 10206175 [TBL] [Abstract][Full Text] [Related]
14. Development of the gamma-aminobutyric acid neurotransmitter system in the rat cerebral cortex during repeated administration of the GABA-transaminase inhibitor ethanolamine O-sulphate. Sykes CC; Horton RW J Neurochem; 1986 Jan; 46(1):213-7. PubMed ID: 3940282 [TBL] [Abstract][Full Text] [Related]
15. Plasticity of rat central inhibitory synapses through GABA metabolism. Engel D; Pahner I; Schulze K; Frahm C; Jarry H; Ahnert-Hilger G; Draguhn A J Physiol; 2001 Sep; 535(Pt 2):473-82. PubMed ID: 11533137 [TBL] [Abstract][Full Text] [Related]
16. Regulation of GAD expression in rat pancreatic islets and brain by gamma-vinyl-GABA and glucose. Petersen JS; Rimvall K; Jørgensen PN; Hasselager E; Moody A; Hejnaes K; Clausen JT; Dyrberg T Diabetologia; 1998 May; 41(5):530-5. PubMed ID: 9628269 [TBL] [Abstract][Full Text] [Related]
17. The effects of in vivo inactivation of GABA-transaminase and glutamic acid decarboxylase on levels of GABA in the rat retina. Cubells JF; Blanchard JS; Makman MH Brain Res; 1987 Sep; 419(1-2):208-15. PubMed ID: 3676726 [TBL] [Abstract][Full Text] [Related]
18. Co-administration of gamma-vinyl GABA and cocaine: preclinical assessment of safety. Molina PE; Ahmed N; Ajmal M; Dewey S; Volkow N; Fowler J; Abumrad N Life Sci; 1999; 65(11):1175-82. PubMed ID: 10503933 [TBL] [Abstract][Full Text] [Related]
19. Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory activity. Sherif F; Harro J; el-Hwuegi A; Oreland L Pharmacol Biochem Behav; 1994 Dec; 49(4):801-5. PubMed ID: 7886090 [TBL] [Abstract][Full Text] [Related]
20. Effect of inhibitors of GABA aminotransferase on the metabolism of GABA in brain tissue and synaptosomal fractions. Löscher W J Neurochem; 1981 Apr; 36(4):1521-7. PubMed ID: 7264649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]